GANX GAIN THERAPEUTICS INC Capital Structure Changes 8-K Filing 2024 - Stock Offering Gain Therapeutics, Inc. has entered into an agreement with Oppenheimer & Co. to sell up to $50 million of its common stock through an at-the-market offering.Get access to all SEC 8-K filings of the GAIN THERAPEUTICS INC